Skip to content

Dantrolene Sodium

Dantrolene Sodium comes in 15 pill versions in our database, in 4 strengths, from 7 manufacturers. Check the imprint to tell them apart.

Dantrolene Sodium pill images

25 mg 5 pills

50 mg 3 pills

100 mg 4 pills

Other 3 pills

What is Dantrolene Sodium used for?

Dantrolene Sodium is used for multiple sclerosis and muscle stiffness (spasticity).

Medicine type
Muscle relaxant
Official uses from the US prescribing label

In Chronic Spasticity:

Dantrolene sodiumis indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. Dantrolene sodiumis not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.

If improvement occurs, it will ordinarily occur within the dosage titration (see DOSAGE AND ADMINISTRATION ), and will be manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrolene sodium.

Occasionally, subtle but meaningful improvement in spasticity may occur with dantrolene sodiumtherapy. In such instances, information regarding improvement should be solicited from the patient and those who are in constant daily contact and attendance with him. Brief withdrawal of dantrolene sodiumfor a period of 2 to 4 days will frequently demonstrate exacerbation of the manifestations of spasticity and may serve to confirm a clinical impression.

A decision to continue the administration of dantrolene sodiumon a long-term basis is justified if introduction of the drug into the patient's regimen:

produces a significant reduction in painful and/or disabling spasticity such as clonus, or

permits a significant reduction in the intensity and/or degree of nursing care required, or

rids the patient of any annoying manifestation of spasticity considered important by the patient himself.

In Malignant Hyperthermia:

Oral dantrolene sodiumis also indicated preoperatively to prevent or attenuate the development of signs of malignant hyperthermia in known, or strongly suspect, malignant hyperthermia susceptible patients who require anesthesia and/or surgery. Currently accepted clinical practices in the management of such patients must still be adhered to (careful monitoring for early signs of malignant hyperthermia, minimizing exposure to triggering mechanisms and prompt use of intravenous Dantrolene Sodium and indicated supportive measures should signs of malignant hyperthermia appear); see also the package insert for Dantrium ®(dantrolene sodium) Intravenous.

Oral dantrolene sodiumshould be administered following a malignant hyperthermic crisis to prevent recurrence of the signs of malignant hyperthermia.

From the FDA-approved label on DailyMed (published Sep 23, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.